Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Wall Street Zen Downgrades Merck & Co. to Hold

Guavy AI Editorial Team
Instruments
GS MRK
Share

Wall Street Zen has downgraded Merck & Co., Inc. (NYSE:MRK) to 'Hold' from 'Buy', according to a report released on Saturday.

This move follows other recent changes in analyst ratings for the company, with Daiwa Securities Group upgrading its rating to 'outperform' and setting a price target of $143.00 per share, while Goldman Sachs increased its target price to $160.00 and gave Merck & Co., Inc. a 'buy' rating.

The current consensus rating for Merck & Co., Inc. is 'Moderate Buy', with 16 analysts recommending 'Buy' and 11 advising 'Hold'. The company's consensus target price stands at $145.76 per share.

More on Stocks

Stocks 8m ago

Motley Fool Flashes Rare Signal for Struggling Anthropic AI

Stocks 9m ago

Pharmas Pour Billions into Early-Stage Chinese Assets

Stocks 11m ago

US Visa Bond Program Targets 50 Countries with Up to $20,000 Deposits

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy